Hematopoietic stem cell

== Hematopoietic Stem Cell ==
Hematopoietic stem cells (HSCs) are the stem cells that give rise to other blood cells. This process is called hematopoiesis. In hematopoiesis, the HSCs reside in the bone marrow and differentiate into various types of blood cells, including red blood cells, white blood cells, and platelets.
Characteristics[edit]
Hematopoietic stem cells are characterized by their ability to self-renew and differentiate into multiple blood cell lineages. They are typically identified by specific cell surface markers, such as CD34 and CD38.
Types of Hematopoietic Stem Cells[edit]
HSCs can be broadly classified into two types:
- Long-term HSCs (LT-HSCs): These cells have the ability to self-renew and sustain hematopoiesis over the lifetime of an individual.
- Short-term HSCs (ST-HSCs): These cells have a limited capacity for self-renewal and contribute to hematopoiesis for a shorter duration.
Sources of Hematopoietic Stem Cells[edit]
Hematopoietic stem cells can be obtained from several sources:
- Bone marrow: The traditional source of HSCs, harvested directly from the bone marrow.
- Peripheral blood: HSCs can be mobilized from the bone marrow into the bloodstream and collected through a process called apheresis.
- Umbilical cord blood: HSCs can be collected from the blood remaining in the umbilical cord and placenta after birth.
Clinical Applications[edit]
Hematopoietic stem cells are used in various clinical applications, primarily in the treatment of hematologic diseases such as leukemia, lymphoma, and aplastic anemia. The transplantation of HSCs, known as hematopoietic stem cell transplantation (HSCT), can restore normal hematopoiesis in patients with these conditions.
Research and Future Directions[edit]
Research on hematopoietic stem cells is ongoing, with a focus on understanding the mechanisms of self-renewal and differentiation, improving transplantation outcomes, and exploring new therapeutic applications. Advances in gene therapy and regenerative medicine hold promise for expanding the use of HSCs in treating a wider range of diseases.
See Also[edit]
- Stem cell
- Hematopoiesis
- Bone marrow
- Leukemia
- Lymphoma
- Aplastic anemia
- Gene therapy
- Regenerative medicine
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
